Acea Biosciences Is A Biotechnology Company Based In San Diegocaliforniawith Additional Manufacturing And R&D Operations In Hangzhouchinafounded In 2002The Company Became Part Of Agilent Technologies In September 2018Acea Biosciences Focuses On Developing And Commercializing High Performance Cell Analysis Platforms For Life Science Research The Company S Primary Products Include The Xcelligence Systemwhich Offers Real Timelabel Free Cell Analysisand The Novocyte Benchtop Flow Cytometerthese Platforms Are Utilized In Various Research Areasincluding Cancer Immunotherapytoxicologyand Basic Academic Studiesacea Biosciences Has Placed Over 1 700 Instruments Worldwidecontributing To More Than 700 Peer Reviewed Publications In The Field Acea Biosciences Is Committed To Advancing Biotechnology Through Innovative Research And Developmentwith A Focus On Areas Such As Allergology And Cardiac Arrhythmiathe Company Has Actively Filed Patents To Support Its Research Initiatives
